cardiovascular diseases
http://www.yso.fi/onto/yso/p9886
Related publications and other outputs
- Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban : an international multicentre single-arm clinical trial (2020) Barco, Stefano; et al.; A1; OA
- Handgrip strength is inversely associated with fatal cardiovascular and all-cause mortality events (2020) Laukkanen, Jari A.; et al.; A1; OA
- Handgrip strength is not associated with risk of venous thromboembolism : a prospective cohort study (2020) Kunutsor, Setor K.; et al.; A1
- Heart Failure Risk Reduction : Hydrophilic or Lipophilic Statins? (2020) Kunutsor, Setor K.; et al.; B1
- Physical activity and risk of venous thromboembolism : systematic review and meta-analysis of prospective cohort studies (2020) Kunutsor, Setor K.; et al.; A2; OA
- Relation of maximal systolic blood pressure during exercise testing to the risk of sudden cardiac death in men with and without cardiovascular disease (2020) Jae, S. Y.; et al.; B1
- Response to letter by Peng-Wu and Ma on: the relationship of cardiorespiratory fitness and venous thromboembolism: yes or no? (2020) Kunutsor, Setor K.; et al.; B1
- Running away from cardiovascular disease at the right speed : the impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes (2020) Mehta, Anurag; et al.; A2; OA
- American Heart Association’s Cardiovascular Health Metrics and Risk of Cardiovascular Disease Mortality Among a Middle-aged Male Scandinavian Population (2019) Isiozor, Nzechukwu M.; et al.; A1
- Associations of Aerobic Fitness and Maximal Muscular Strength With Metabolites in Young Men (2019) Kujala, Urho M.; et al.; A1; OA